Submitted by Bloodworks Northwest
With new COVID-19 cases in the Northwest projected to decline in the weeks ahead, Washington and Oregon hospitals are preparing to re-start surgeries, organ transplants and cancer treatments that were suspended in March after the magnitude of the pandemic threat became apparent. Patient needs and requests for blood from Bloodworks healthcare partners are rising quickly and could reach pre-COVID levels as early as next week before the blood supply is ready.
Whenthe coronavirus hit, donors in the community stepped up immediately, said CurtBailey, President and CEO of Bloodworks Northwest. As we start the challengingroad to recovery, patients need them even more.
Hospitals and healthcare providers in the region are preparing to tackle a significant backlog of surgeries, medical treatments and procedures that require transfusions. Mounting requests from hospitals are outpacing current collection levels. We cannot afford to re-start these and other treatments without being utterly certain the blood will be there and steadily available over the coming days and months, and only the community can close the gap, Bailey said.
Essential measures to contain the coronavirus stay-at-home orders, online learning at colleges and schools, workplace and business closures, social distancing to discourage public and faith-based gatherings also took away usual settings for mobile blood drives that account for up to 60% of collections (the equivalent of 34,000 units since March 1). The sacrifices necessary for a safe and healthy community have been felt and shared by everyone, Bailey noted. After conserving the blood supply in recent weeks, we must rebuild inventory to a higher, resilient level that will propel the community toward a safe, sustainable recovery.
Bloodworks has implemented some creative new approaches to blood collection, said Vicki Finson, Executive Vice President of Blood Services. With donor support, we can make the most of them to restore the blood supply for people whove been patiently awaiting their turn. Were determined to be ready for patients and to support our healthcare partners, however, right now the need is outpacing the supply. Only by boosting current collections and calling on donors to book appointments can we meet the critical need hospitals have identified for the weeks ahead.
Inextraordinary times like these (and in normal times, too) the community bloodsupply supports patients receiving trauma care, undergoing surgeries, cancertreatment, organ transplants, plus new moms and neonatal care.
Bloodworks is urging all donors to step up for community recovery.Please pre-book your next severaldonations now to make sure patients get the fighting chance andlifesaving blood they deserve. All types are urgently needed, but Type O isespecially in demand.
Theblood components in greatest demand are perishable, just like milk. Plateletshave a shelf-life of only 5 days; red cells can be stored for up to 42 days.Thats why donors are needed every day. The community will have a safe andreliable blood supply when donating blood becomes a kindhearted habitwhendonors commit to donating two or three times per year or more.
Wewelcome regular and new donors as humble heroes to save lives and to help inCOVID recovery.
Now more than ever the act of donating blood is a way for peopleto look after their families,friends, coworkers and neighbors, Bailey said. Whenit comes to a safe and resilient blood supply, lets be the community thatleads the nation.
Before COVID-19,about 60% of the blood supply was collected through mobile drives hosted bydrive sponsors who organized drives at schools, workplaces, offices, factories,communityspaces and places of worship. Due to social distancing, Bloodworks is no longerdoing one-time only mobile drives. Instead, pop-up donor centers aremulti-week drives in spacious, temporary venues like T-Mobile Park, Cheney Stadium, Angel of the Winds Arena along with manyother area businesses and churches which are providing the opportunity forhundreds of donor appointments per day. Extended hours at donor centersalso play a key role.
Whole blood donors can giveblood once every 56 days, up to 6 times a year. Those aged 16 & 17 who meetdonation weight and eligibility requirements may donate with a signed Bloodworkspermission form.
Appointments arerequired to donate blood, and no guests or people under the age of 16 arepermitted onsite to support safe social distancing, minimize wait time, andensure the best donation experience possible. Same day appointments are oftenavailable by calling ahead to 800-398-7888. Special appointments have beenreserved for donors who are blood type O negative in this crucial time, soplease contact us at 800-398-7888 or email schedule@bloodworksnw.org if this is your blood type.
Donating blood is safe, and there is no risk of contracting coronavirus from the donation process. (Source: AABB) Bloodworks policies comply with FDA, CDC, local health departments and other recommendations related to COVID-19. Bloodworks follows CDC guidance on wearing masks by wearing cloth face masks donated by volunteers or a face shield. We encourage donors to wear masks to their donation appointments and whenever they are in public. Bloodworks routinely sanitizes donation areas, chairs, surfaces and common objects such as doorknobs and light switches, and use hand sanitizer. Staff, donors, and volunteers are advised to stay home if they feel unwell. Bloodworks has posted information addressing questions and concerns for blood donors at bloodworksnw.org/coronavirus.
Blood donation takes about an hour from registration to post-donation refreshment. Information about who can donate and where is available at http://www.bloodworksnw.org.
For the latest information on COVID-19 please visit theCDC website and Washington State Department of Health COVID-19 main page.
Appointments and information at BloodworksNW.org or800-398-7888..
Bloodworks Northwest is backed by 75 years of Northwest history and 250,000 donors. It is local, nonprofit, independent, volunteer-supported and community-based. A recognized leader in transfusion medicine, Bloodworks serves patients at hospitals in Washington, Oregon and Alaska partnering closely with local hospitals to deliver the highest level of patient care. Comprehensive services include blood components, complex cross-matching, specialized lab services for organ transplants, care for patients with blood disorders, and collection of cord blood stem cells for cancer treatment. Bloodworks Research Institute performs leading-edge research in blood biology, transfusion medicine, blood storage and treatment of blood disorders. Patients with traumatic injuries, undergoing surgeries or organ transplantation or receiving treatment for cancer and blood disorders all depend on our services, expertise, laboratories and research. Blood donation appointments can be scheduled at bloodworksnw.org.
See the article here:
Hospitals to Resume Elective Surgeries, Triggering a Surge in Blood Needs - southsoundtalk.com
- LMRUK: New mothers share why theyre banking their babies cord blood stem cells - Charity Today News - November 29th, 2024
- scRNA-seq revealed transcriptional signatures of human umbilical cord primitive stem cells and their germ lineage origin regulated by imprinted genes... - November 26th, 2024
- Cord Blood Banking FAQs - Cord For Life - November 25th, 2024
- Hematopoietic Stem Cell Transplantation Market: Industry Analysis and Forecast 2024-2033 - openPR - November 22nd, 2024
- Thousands of donations, fewer than 2% used. Why cord blood transplants are so rare - CBC News - November 18th, 2024
- Stem cells: the alternative solution to umbilical cord blood - Genethique - November 10th, 2024
- Chapter 64 Role of Umbilical Cord Blood Transplantation - October 30th, 2024
- Major Trend Transforming the Stem Cell Market in 2024: Advancements in Automated Stem Cell Analysis Systems - EIN News - October 30th, 2024
- Stem cell therapies for neurological disorders: current progress ... - October 22nd, 2024
- OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients - AsiaOne - October 18th, 2024
- Click N' Play STEM Lesson on Cord Blood Launches for Teachers this November - EIN News - October 18th, 2024
- Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy - HealthDay - October 4th, 2024
- What Are Leukemia and Lymphoma and How Are They Treated? - LVHN News - September 20th, 2024
- Advanced Treatment for Leukemia and Lymphoma at Lehigh Valley Topper Cancer Institute - LVHN News - September 18th, 2024
- Functional stem cells successfully grown in lab for the first time - The Star Online - September 14th, 2024
- Umbilical Cord Blood Stem Cells as Third-party Adjuvant Infusions in Human Leukocyte Antigen Antibody-Positive Patients Undergoing Haploidentical... - September 12th, 2024
- Cord Blood Banking Market Size to Surpass USD 65.6 Billion by 2032 | With 7.9% CAGR - openPR - September 12th, 2024
- Blood stem cell breakthrough could have massive impact on patients - Yahoo! Voices - September 8th, 2024
- Scientists have grown blood stem cells in the laboratory - TURKMENPORTAL - September 4th, 2024
- Global Cord Blood Product Market Poised for Significant Growth: Projected to Reach USD 1,341.7 Million by 2034 | Future Market Insights, Inc. - Yahoo... - September 2nd, 2024
- Global Allogeneic Stem Cell Transplantation Market Expected to Grow to $6.75 Billion by 2031 - WhaTech - August 31st, 2024
- Global Cord Blood Product Market Poised for Significant Growth: Projected to Reach USD 1,341.7 Million by 2034 | Future Market Insights, Inc. -... - August 31st, 2024
- Expansion Of Cord Blood-derived CD34 Cells In A Hollow-Fiber Bioreactor With 10% Standard Cytokine Concentration - BioProcess Online - August 22nd, 2024
- New Study: These Bizarre Blood-Sucking Fish Have a Jaw-Dropping Evolutionary Origin - SciTechDaily - July 31st, 2024
- Cord blood banking industry faces scrutiny over unproven claims and high costs - News-Medical.Net - July 28th, 2024
- Stem cells donated 15 years ago let poorly boy, five, leave home for the first time in six months - Express & Star - July 26th, 2024
- Cord blood stem cells transferred from Guangdong to treat girl with thalassemia - Hong Kong Standard - July 26th, 2024
- Cord Blood Banking Curative Benefits Often Oversold to Parents: NYT Investigation - AboutLawsuits.com - July 22nd, 2024
- Umbilical cord stem cells donated in 2008 transform life of five-year-old boy with rare genetic disorder - The Independent - July 22nd, 2024
- Boy, 5, diagnosed with deadly rare condition has life transformed after stem cell transplant from umbilical cord blood - Sky News - July 22nd, 2024
- Stem cells donated 15 years ago let poorly boy, five, leave home for the first time in six months - Shropshire Star - July 22nd, 2024
- Ottawa mother raising awareness on importance of donating umbilical cord blood - CTV News Ottawa - July 22nd, 2024
- Inside a blood cord bank: How facilities store and maintain the quality of units - CNA - July 8th, 2024
- Exploring the potential of predicted miRNAs on the genes involved in the expansion of hematopoietic stem cells ... - Nature.com - July 5th, 2024
- Overview of Umbilical Cord Blood - Stanford Medicine - July 5th, 2024
- Comparison of the therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells and adipose ... - Frontiers - July 5th, 2024
- A Review of Placenta and Umbilical Cord-Derived Stem Cells and the Immunomodulatory Basis of Their Therapeutic ... - Frontiers - July 2nd, 2024
- Jacques Galipeau, MD, on International Insights Into Cell and Gene Therapy Development - CGTLive - June 30th, 2024
- Stem Cell Therapy Market to Hit $63.23 billion by 2031, at a CAGR of 22.6%, says Coherent Market Insights - GlobeNewswire - June 28th, 2024
- Hematopoietic stem cell transplantation (HSCT) Market Future Growth Trends, Upcoming Opportunities and ... - openPR - June 24th, 2024
- Global Biopreservation Market Forecast Report 2024-2029: Advances in Biobanking and Growing Trend of Conserving ... - GlobeNewswire - June 4th, 2024
- Cord Blood Banking Services Market to Witness Impressive Growth, Reaching USD 4.5 Billion by 2030 - EIN News - May 27th, 2024
- Department of Health Abu Dhabi and M42 launch regions largest hybrid cord blood bank - ZAWYA - May 15th, 2024
- Cord Blood Banking - Stanford Medicine Children's Health - May 8th, 2024
- Umbilical Cord Blood Transplants: Current Status and Evolving Therapies - May 8th, 2024
- Embattled Cordlife receives letter of demand from client for breach of contract - The Straits Times - May 4th, 2024
- From Cord Blood to Microbiome; The evolution of Rotary's gift to the people of WA - Lifeblood - May 2nd, 2024
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune ... - Nature.com - April 28th, 2024
- Hitting the pavement for cord blood research | Cranbourne Star News - Cranbourne Star News - April 28th, 2024
- One year to test 200 Cordlife samples 'totally unjustified': Global cord blood banking experts - The Straits Times - April 15th, 2024
- Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells - Medical Xpress - April 7th, 2024
- The umbilical cord: a rich and ethical stem cell source to advance ... - March 30th, 2024
- Story of discovery: getting a Notch up on cord blood cell ... - March 30th, 2024
- Cord Blood Transplants | Memorial Sloan Kettering Cancer Center - March 30th, 2024
- Therapeutic effect and study of human umbilical cord blood mononuclear cells in patients with ischaemic bowel ... - Nature.com - March 17th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024: The Vast Majority of the Global Cord Blood Market is Now ... - PR Newswire - March 15th, 2024
- Improving Transplant Outcomes and Cell Therapy Approaches - RegMedNet - March 9th, 2024
- The inhibition of ADAM17 in cord blood stem cell-derived CD16+ NK cells to enhance their cytotoxicity against acute ... - ScienceDirect.com - March 1st, 2024
- Beating Blood Cancer through Recycling - a Community crowdfunding project in Liverpool by Kate Williams - Crowdfunder UK - February 24th, 2024
- Cord Blood Registry (CBR ) by CooperSurgical and Fulgent Genetics Launch Innovative Genetic Testing - Investing.com Canada - February 9th, 2024
- Young cancer patient with 'no hope' of recovery saved by baby's umbilical cord - Study Finds - February 9th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN - January 26th, 2024
- Finding the optimal combination of anticancer drug administration for the conditioning of cord blood transplantation - Medical Xpress - January 26th, 2024
- Cord Blood Banking Market Sales and Revenue Report 2023-2032 - WhaTech Technology and Markets News - January 26th, 2024
- Global Cord Blood & Tissue Banking Industry Report 2024 - The Vast Majority of the Global Cord Blood Market is Now ... - ACROFAN USA - January 24th, 2024
- Global Biobanking Market Size To Exceed USD 97.5 Billion By 2032 | CAGR of 5.8% - GlobeNewswire - January 24th, 2024
- The use of cryopreservation in life saving research - The Manufacturer - January 24th, 2024
- CD19-targeted CAR NK cell therapy achieves promising one-year results in patients with B-cell malignancies - Medical Xpress - January 18th, 2024
- Cord blood banking comes at a high cost to babies - STAT - STAT - January 18th, 2024
- Global Cord Blood and Tissue Banking Industry Gains Traction Amidst Surging M&A Activity and Technological Advances - PR Newswire - January 16th, 2024
- Donating Bone Marrow and Stem Cells: The Process and What To Expect - On Cancer - Memorial Sloan Kettering - January 11th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 4th, 2024
- askST: Can cord blood units be transferred from one bank to another? - The Straits Times - December 27th, 2023
- Timeline: Cordlife's mishandling of cord blood units in Singapore - CNA - December 15th, 2023
- Next-Level Evolution: Enhancing the Human Body With Anthrobots ... - Securities.io - December 5th, 2023
- Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ... - Fred Hutchinson Cancer Center - December 5th, 2023
- Enhancing the immunosuppressive properties of human umbilical ... - Phys.org - December 1st, 2023
- Global Status and Trends for Thromboangiitis Obliterans | JPR - Dove Medical Press - December 1st, 2023
- Early Stage Cell Therapy Trial Shows Promise in Treating Progressive Multiple Sclerosis - University of Colorado Anschutz Medical Campus - December 1st, 2023
- Global Medical Specialty Bag Market is Expected to Reach US$ 9.4 Billion by 2034, Rising at a Steady 4.7% CAGR | Future Market Insights, Inc. - Yahoo... - November 29th, 2023
Recent Comments